Delos Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.9K Hold
310
0.02% 143
2025
Q4
$29.8K Hold
310
0.02% 118
2025
Q3
$29.5K Hold
310
0.02% 137
2025
Q2
$27K Buy
+310
New +$26.3K 0.02% 127
2025
Q1
Sell
-310
Closed -$24.8K 132
2024
Q4
$24.8K Hold
310
0.02% 93
2024
Q3
$27.9K Hold
310
0.02% 91
2024
Q2
$24.4K Hold
310
0.02% 94
2024
Q1
$27K Hold
310
0.03% 82
2023
Q4
$25.5K Hold
310
0.04% 80
2023
Q3
$25.3K Hold
310
0.03% 95
2023
Q2
$27.3K Hold
310
0.03% 85
2023
Q1
$25K Hold
310
0.03% 85
2022
Q4
$24.1K Hold
310
0.04% 89
2022
Q3
$25K Hold
310
0.03% 77
2022
Q2
$28K Hold
310
0.03% 76
2022
Q1
$34K Sell
310
-153
-33% -$16.2K 0.03% 84
2021
Q4
$48K Sell
463
-37
-7% -$4.28K 0.05% 77
2021
Q3
$63K Hold
500
0.07% 54
2021
Q2
$62K Buy
+500
New +$62.8K 0.08% 51

Other funds holding MDT

Delos Wealth Advisors's MDT Position: Q1 2026 in Review

Delos Wealth Advisors held its Medtronic (MDT) position steady in Q1 2026 at 310 shares worth $26.9K. The position accounts for 0.02% of the portfolio, ranked #143.

Delos Wealth Advisors first reported a position in MDT in Q2 2021 and has held it in 19 quarters since. The position peaked at $63K in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Delos Wealth Advisors held 310 shares of Medtronic worth $26.9K as of Q1 2026.
  • Delos Wealth Advisors left its Medtronic share count unchanged in Q1 2026.
  • Medtronic made up 0.02% of Delos Wealth Advisors's portfolio in Q1 2026, its #143 holding.
  • Delos Wealth Advisors first reported a position in Medtronic in Q2 2021 and has held it in 19 quarters since.
  • Delos Wealth Advisors's Medtronic position peaked at $63K in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Delos Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.